Sanofi

News

After missing out on CEO job, Novo's US head quits

The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.

News

Sanofi cholesterol drug can stay on US market - for now

Sales of Praluent can continue during patent case appeal.

News

New general manager and diabetes medical leader for Sanofi U...

Hugo Fry and Dr Hubert Bland take on new roles at Sanofi UK

News

Sanofi's Kevzara gains first approval in Canada

Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.

News

Sanofi diabetes combo approved in EU

Drug will compete against Novo Nordisk's Xultophy.

News

New NICE rules could deny drugs to rare disease patients

Patients could be denied treatments, says BIA

After missing out on CEO job, Novo's US head quits

Sanofi cholesterol drug can stay on US market - for now

New general manager and diabetes medical leader for Sanofi U...

Sanofi's Kevzara gains first approval in Canada

Sanofi diabetes combo approved in EU

New NICE rules could deny drugs to rare disease patients

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

Sanofi

Editor's Picks